A Study of V118E in Healthy Participants (V118E-003)
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
- Status
- RECRUITING
- Phase
- PHASE4
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
- Status
- RECRUITING
- Phase
- PHASE2
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)
- Status
- COMPLETED
- Phase
- PHASE1
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- Status
- RECRUITING
- Phase
- PHASE3
MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Status
- RECRUITING
- Phase
- PHASE2